We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), a $15.77 billion market cap company with an "Excellent" financial health rating according to InvestingPro, executed a ...

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “market perform” rating restated by analysts at Oppenheimer in a research note issued to investors on Monday, MarketBeat.com reports ...

The United States market has been flat in the last week, but it has risen by 20% over the past 12 months, with earnings expected to grow by 15% per annum in the coming years. In this environment, ...

Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective boosted by analysts at Leerink Partners from $110 ...

SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare ...

Constantine Chinoporos, the Chief Operating Officer and Chief Business Officer of Applied Therapeutics, Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company with a market capitalization of ...

Cynata Therapeutics Limited ( OTCPK:CYYNF) Investor Webinar Conference Call February 5, 2025 6:30 PM ET Lauren Nowak - Media Relations Kilian Kelly - Chief Executive Officer and Managing Director ...